Neftaly Health and Wellness Services

NeftalyApp COURSES Partner INVEST Corporate CHARITY Divisions

[Contact SayPro] [About SayPro][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material] [ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships] [Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Tag: of

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Written by

Mapaseka Matabane

in

  • Neftaly Management of Pediatric Epilepsy

    Neftaly Management of Pediatric Epilepsy

    Neftaly Management of Pediatric Epilepsy

    1. Introduction

    Epilepsy is one of the most common neurological disorders in children, characterized by recurrent, unprovoked seizures. While pediatric epilepsy can be a lifelong condition, many children can live healthy and productive lives with early diagnosis, appropriate treatment, and ongoing support.

    Neftaly is committed to reducing the burden of pediatric epilepsy through evidence-based care, community education, and accessible treatment models, especially in resource-limited and rural settings.

    2. Objectives

    • Improve early identification and accurate diagnosis of epilepsy in children.
    • Guide appropriate treatment using safe and effective anti-seizure medications.
    • Reduce seizure frequency and associated complications.
    • Promote social inclusion and reduce stigma.
    • Support families and caregivers through education and community resources.

    3. Understanding Pediatric Epilepsy

    3.1 Definition

    Epilepsy is defined as:

    • Two or more unprovoked seizures occurring more than 24 hours apart, OR
    • One unprovoked seizure with a high risk (>60%) of recurrence, OR
    • A diagnosed epilepsy syndrome

    3.2 Common Causes in Children

    Age GroupCommon Causes
    Neonates (0–1 month)Birth injury, infections, metabolic disorders, genetic conditions
    Infants and childrenFebrile seizures, cerebral palsy, trauma, tumors, developmental disorders
    AdolescentsGenetic epilepsy syndromes, head trauma, infections, substance use

    4. Types of Seizures

    Seizure TypeFeatures
    Focal (Partial)Begins in one area of the brain; may involve abnormal movements, awareness changes
    Generalized Tonic-ClonicFull-body convulsions, loss of consciousness, post-ictal confusion
    AbsenceBrief staring spells, unresponsive, sudden stop in activity
    MyoclonicSudden, brief muscle jerks
    AtonicSudden loss of muscle tone, may cause falls
    Febrile SeizuresTriggered by fever; usually outgrown by age 5

    5. Diagnosis

    5.1 Clinical Evaluation

    • Detailed seizure history: onset, frequency, duration, triggers, behavior during and after seizure
    • Family history of epilepsy or neurological conditions
    • Developmental milestones and physical exam

    5.2 Investigations

    • EEG (Electroencephalogram): to confirm seizure type or syndrome
    • Neuroimaging (MRI preferred over CT): if focal signs, developmental delay, or abnormal neurological findings
    • Metabolic and genetic testing if clinically indicated

    6. Acute Seizure Management

    6.1 First Aid During a Seizure

    • Stay calm; lay the child on their side (recovery position)
    • Protect from injury (remove harmful objects, loosen tight clothing)
    • Do NOT restrain the child or put anything in their mouth
    • Time the seizure; if it lasts >5 minutes, seek emergency care

    6.2 Emergency Medication for Prolonged Seizures

    • Rectal Diazepam or Buccal Midazolam (as per protocol)
    • Refer to a health facility if:
      • Seizure lasts >5 minutes
      • Repeated seizures without recovery
      • Child is injured or has breathing difficulties

    7. Long-Term Treatment

    7.1 Anti-Seizure Medications (ASMs)

    MedicationUseNotes
    PhenobarbitalNeonatal seizures, generalizedEffective and affordable; may cause drowsiness
    CarbamazepineFocal seizuresNot for generalized epilepsy
    Valproic AcidGeneralized, absence, myoclonicAvoid in adolescent females due to teratogenicity
    LamotrigineBroad-spectrumGood safety profile
    LevetiracetamBroad-spectrumFewer interactions; well-tolerated
    • Start with monotherapy, increase gradually to effective dose.
    • Monitor for side effects, compliance, and drug interactions.
    • Maintain treatment for at least 2 years seizure-free before considering tapering.

    7.2 Monitoring and Follow-Up

    • Regular growth and development checks
    • Medication adherence and side effects
    • School performance and psychosocial well-being
    • Periodic EEG or imaging (if needed)

    8. Non-Pharmacological Management

    • Ketogenic diet: High-fat, low-carb diet for refractory epilepsy (requires medical supervision)
    • Vagus Nerve Stimulation (VNS): For drug-resistant epilepsy (where available)
    • Psychosocial support: Mental health care, peer groups, school counseling
    • Neurosurgery: In selected cases with identifiable seizure focus

    9. Family and Caregiver Support

    Neftaly promotes:

    • Education on seizure recognition and response
    • Guidance on medication administration and adherence
    • Safety at home and school (helmets, supervision, swimming precautions)
    • Support groups and caregiver mental health

    10. Addressing Stigma and Inclusion

    • Train community health workers to educate families and schools
    • Raise public awareness that epilepsy is not contagious or spiritual
    • Promote inclusive education and community participation
    • Work with schools to develop seizure action plans

    11. Referral Guidelines

    Refer to a specialist if:

    • Seizures are not controlled after 2 appropriate medications
    • Developmental delay or regression occurs
    • Suspicion of structural brain lesion or genetic disorder
    • Diagnosis is unclear or non-epileptic events are suspected

    12. Data Collection and Monitoring

    • Use standard epilepsy registers to track diagnosed children
    • Monitor:
      • Seizure frequency and type
      • Medication use and side effects
      • School attendance and behavior
    • Report drug stock-outs or treatment gaps to Neftaly’s Health Systems Unit

    13. Neftaly Community Outreach Model

    • Mobile clinics to identify and manage epilepsy in rural areas
    • Training for primary care providers and CHWs on epilepsy care
    • Family education workshops in collaboration with local leaders
    • Referral networks for advanced diagnosis and treatment

    14. Conclusion

    Pediatric epilepsy is treatable and manageable. With early diagnosis, continuous care, and community support, children with epilepsy can lead full, active lives. Neftaly is dedicated to making epilepsy care equitable, affordable, and stigma-free through integrated services and strong community partnerships.

    For clinical tools, referral forms, training materials, or support services, contact the Neftaly Child Neurology and Disability Program.

  • Neftaly Management of Hypertensive Disorders in Pregnancy

    Neftaly Management of Hypertensive Disorders in Pregnancy

    Neftaly Management of Hypertensive Disorders in Pregnancy

    1. Introduction

    Hypertensive disorders are among the leading causes of maternal and perinatal morbidity and mortality globally. Timely detection and appropriate management are crucial to saving the lives of both mothers and babies.

    Neftaly is committed to improving maternal health outcomes by equipping healthcare providers with standardized, evidence-based protocols for identifying, managing, and preventing complications associated with hypertensive disorders during pregnancy.

    2. Objectives

    • Improve early detection of hypertensive disorders during pregnancy.
    • Standardize clinical management at all levels of care.
    • Reduce maternal and neonatal mortality associated with complications.
    • Promote referral systems and emergency preparedness.
    • Empower communities with awareness and education.

    3. Classification of Hypertensive Disorders in Pregnancy

    ConditionDefinition
    Gestational HypertensionNew-onset hypertension after 20 weeks of gestation without proteinuria or signs of organ damage.
    Chronic HypertensionHypertension diagnosed before pregnancy or before 20 weeks of gestation.
    PreeclampsiaHypertension after 20 weeks of gestation with proteinuria and/or signs of end-organ dysfunction.
    EclampsiaPreeclampsia with the onset of seizures not attributable to other causes.
    Superimposed PreeclampsiaChronic hypertension with new-onset proteinuria or other features of preeclampsia after 20 weeks.

    4. Screening and Diagnosis

    4.1 Routine Antenatal Screening

    • Check blood pressure at every ANC visit.
    • Screen for proteinuria using dipsticks or urine analysis.
    • Monitor for signs: headaches, blurred vision, right upper quadrant pain, swelling of face/hands.

    4.2 Diagnostic Criteria

    ConditionCriteria
    HypertensionSBP ≥ 140 mmHg or DBP ≥ 90 mmHg (measured twice, 4–6 hours apart)
    Severe HypertensionSBP ≥ 160 mmHg or DBP ≥ 110 mmHg
    Proteinuria≥ 300 mg/24h or ≥ +1 on dipstick
    Severe FeaturesElevated liver enzymes, low platelets, renal dysfunction, pulmonary edema, visual disturbances

    5. Management Protocols

    5.1 Gestational and Chronic Hypertension (No Severe Features)

    • Monitor: BP every 1–2 weeks, urine protein, fetal growth.
    • Medication: Methyldopa, labetalol, or nifedipine as first-line options.
    • Delivery: Plan delivery at 37–39 weeks if stable.

    5.2 Preeclampsia Without Severe Features

    • Monitoring: Twice weekly BP and labs (LFTs, CBC, renal function).
    • Medication: Antihypertensives to maintain BP < 150/100 mmHg.
    • Fetal Surveillance: NST, ultrasound for growth and amniotic fluid.
    • Delivery: At 37 weeks or earlier if deterioration occurs.

    5.3 Preeclampsia With Severe Features

    • Admission to hospital.
    • Control BP: Rapid-acting agents (IV labetalol, hydralazine).
    • Seizure prophylaxis: Magnesium sulfate (loading and maintenance doses).
    • Labs: LFTs, platelets, renal function every 1–2 days.
    • Fetal assessment: Continuous monitoring if viable.
    • Delivery: Immediate if gestational age ≥34 weeks or if maternal/fetal condition worsens.

    5.4 Eclampsia

    • Emergency care required.
    • Airway and seizure control: Magnesium sulfate is first-line.
    • BP management: As above.
    • Delivery: Once the mother is stabilized — regardless of gestational age.
    • Postpartum care: Continue magnesium sulfate for 24 hours post last seizure.

    6. Magnesium Sulfate Protocol

    Loading dose:

    • 4g IV over 15–20 minutes
    • PLUS 10g IM (5g in each buttock)

    Maintenance dose:

    • 5g IM every 4 hours OR
    • 1–2g/hour IV infusion

    Monitor for toxicity:

    • Check reflexes, respiratory rate (>12/min), urine output (>25ml/hr)
    • Antidote: Calcium gluconate 10% IV 10ml over 10 minutes

    7. Postpartum Management

    • Continue antihypertensives as needed.
    • Monitor BP for 72 hours post-delivery and at 7–10 days postpartum.
    • Educate about risk of future cardiovascular disease and preeclampsia.
    • Schedule follow-up at 6 weeks postpartum.

    8. Referral and Emergency Preparedness

    • Immediate referral for:
      • Severe hypertension or eclampsia
      • Signs of maternal or fetal compromise
      • Uncontrolled BP or deteriorating labs
    • Ensure availability of:
      • Transport and referral protocols
      • Emergency kits (antihypertensives, magnesium sulfate, IV supplies)
      • Stabilization before transfer

    9. Community Awareness and Education

    Neftaly trains Community Health Workers to:

    • Educate pregnant women on warning signs of high blood pressure.
    • Promote early ANC registration.
    • Support medication adherence and follow-up.
    • Facilitate timely referrals.

    10. Data and Monitoring

    • Record blood pressure and symptoms at every contact.
    • Track maternal outcomes: seizures, ICU admission, perinatal outcomes.
    • Use digital tools or ANC registers for tracking high-risk pregnancies.
    • Report severe preeclampsia/eclampsia cases to Neftaly’s Maternity Surveillance Unit.

    11. Training and Capacity Building

    Neftaly supports:

    • On-site and remote training for nurses, midwives, and doctors.
    • Emergency drills and simulation training.
    • Protocol checklists and decision-support tools.
    • Supervision and mentorship visits.

    12. Conclusion

    Hypertensive disorders in pregnancy require vigilant monitoring, prompt management, and a coordinated care approach. Neftaly’s comprehensive strategy ensures that pregnant women receive timely, respectful, and life-saving care — protecting both mother and baby from preventable complications.

    For clinical tools, training materials, or technical support, contact the Neftaly Maternal Health Team.

  • Neftaly Management of Diabetes in Pregnancy

    Neftaly Management of Diabetes in Pregnancy

    Neftaly Management of Diabetes in Pregnancy

    1. Introduction

    Diabetes in pregnancy, including pre-existing diabetes and gestational diabetes mellitus (GDM), poses significant risks to both mother and fetus. Proper management is essential to reduce complications such as preeclampsia, macrosomia, preterm birth, and neonatal hypoglycemia.

    Neftaly’s guidelines provide evidence-based strategies for screening, diagnosis, treatment, and monitoring of diabetes during pregnancy to ensure optimal maternal and neonatal outcomes.

    2. Objectives

    • Early identification of diabetes in pregnancy
    • Maintain maternal glycemic control within target ranges
    • Minimize maternal and fetal complications
    • Promote healthy pregnancy outcomes through multidisciplinary care

    3. Screening and Diagnosis

    3.1 Screening Recommendations

    • Screen all pregnant women at first antenatal visit for pre-existing diabetes if risk factors present (obesity, family history, prior GDM, etc.)
    • Universal screening for GDM between 24–28 weeks gestation using an oral glucose tolerance test (OGTT)

    3.2 Diagnostic Criteria (Based on WHO or ADA guidelines)

    • Fasting plasma glucose ≥ 92 mg/dL (5.1 mmol/L)
    • 1-hour post-OGTT glucose ≥ 180 mg/dL (10.0 mmol/L)
    • 2-hour post-OGTT glucose ≥ 153 mg/dL (8.5 mmol/L)

    4. Management Principles

    4.1 Lifestyle Modification

    • Nutritional counseling focusing on balanced diet with appropriate caloric intake
    • Regular physical activity tailored to pregnancy status
    • Weight management and monitoring

    4.2 Blood Glucose Monitoring

    • Self-monitoring of blood glucose (SMBG) at least four times daily (fasting and postprandial)
    • Target glucose levels:
      • Fasting: 70–95 mg/dL (3.9–5.3 mmol/L)
      • 1-hour postprandial: <140 mg/dL (7.8 mmol/L)
      • 2-hour postprandial: <120 mg/dL (6.7 mmol/L)

    4.3 Pharmacologic Therapy

    • Initiate insulin therapy if glycemic targets are not met after 1–2 weeks of lifestyle modification
    • Use of oral hypoglycemics (e.g., metformin) may be considered under specialist guidance
    • Adjust therapy based on glucose monitoring and gestational age

    4.4 Monitoring and Follow-up

    • Regular antenatal visits every 2–4 weeks, increasing frequency in the third trimester
    • Monitor maternal blood pressure, weight, and urine for protein
    • Ultrasound monitoring of fetal growth and amniotic fluid volume
    • Screening for diabetic complications (retinopathy, nephropathy)

    5. Intrapartum and Postpartum Care

    5.1 Labor Management

    • Monitor maternal glucose levels during labor to maintain 70–110 mg/dL (3.9–6.1 mmol/L)
    • Prepare for possible neonatal hypoglycemia and respiratory distress

    5.2 Postpartum Care

    • Discontinue insulin or oral hypoglycemics unless pre-existing diabetes
    • Screen for persistent diabetes 6–12 weeks postpartum with OGTT
    • Counsel on lifestyle to reduce risk of type 2 diabetes
    • Plan for follow-up and screening in subsequent pregnancies

    6. Complications and Their Management

    ComplicationManagement Strategies
    PreeclampsiaClose monitoring, antihypertensive therapy as needed
    MacrosomiaConsider early delivery if indicated
    Preterm laborTocolytics and corticosteroids for fetal lung maturity
    Neonatal hypoglycemiaEarly feeding and glucose monitoring

    7. Patient Education

    • Emphasize importance of adherence to diet, medication, and monitoring
    • Educate on recognizing symptoms of hypo- and hyperglycemia
    • Support breastfeeding, which improves glucose metabolism postpartum

    8. Challenges and Solutions

    ChallengeNeftaly Approach
    Limited access to glucose testingProvide point-of-care glucometers and training
    Poor adherence to therapyUse counseling and support groups
    Resource constraints for insulinAdvocate for affordable insulin and supplies
    Lack of specialized careTrain primary care providers in diabetes pregnancy management

    9. Conclusion

    Effective management of diabetes in pregnancy is vital to ensuring the health of both mother and baby. Neftaly supports healthcare providers with comprehensive protocols to optimize care throughout pregnancy, delivery, and postpartum.

    For detailed protocols, patient education materials, and training resources, contact Neftaly Maternal Health Services.

  • Neftaly Management of Anemia in Children

    Neftaly Management of Anemia in Children

    Neftaly Management of Anemia in Children

    Strengthening Young Lives Through Early Detection and Effective Care

    Anemia in children is a common yet treatable condition that can significantly affect growth, development, behavior, and overall well-being. At Neftaly, our Management of Anemia in Children program focuses on early diagnosis, targeted treatment, and long-term prevention to ensure children grow strong, healthy, and full of potential.

    Our Mission

    To reduce the impact of childhood anemia by delivering comprehensive, child-focused care—addressing both medical and nutritional needs through evidence-based strategies and family support.

    What Is Anemia in Children?

    Anemia occurs when a child has too few red blood cells or insufficient hemoglobin, which reduces the blood’s ability to carry oxygen to the body’s tissues. The most common type in children is iron-deficiency anemia, but other causes include vitamin deficiencies, chronic illness, infections, or inherited disorders.

    Common Symptoms of Anemia in Children

    • Fatigue or low energy
    • Pale skin, lips, or nail beds
    • Irritability or behavioral changes
    • Poor appetite
    • Shortness of breath or rapid heartbeat
    • Delayed growth or development
    • Frequent infections

    Neftaly’s Approach to Anemia Management

    1. Early Detection and Diagnosis

    • Routine screening, especially in high-risk groups (e.g., infants, toddlers, undernourished children)
    • Laboratory tests including hemoglobin levels, iron studies, and complete blood count (CBC)
    • Evaluation of nutritional intake, growth patterns, and family history

    2. Identifying the Underlying Cause

    • Nutritional deficiencies (iron, B12, folate)
    • Chronic diseases or infections (malaria, TB, HIV)
    • Parasitic infestations (e.g., hookworms)
    • Genetic or hematologic conditions (e.g., thalassemia, sickle cell disease)

    3. Individualized Treatment Plans

    • Nutritional intervention: Iron-rich foods, fortified cereals, vitamin supplementation
    • Iron therapy: Oral iron supplements with follow-up to ensure response
    • Treatment of underlying conditions: Deworming, infection control, management of chronic illness
    • Blood transfusions: For severe or life-threatening anemia
    • Monitoring and follow-up: Regular tracking of hemoglobin and growth indicators

    4. Parent and Caregiver Education

    • Guidance on iron-rich diets (meat, legumes, leafy greens, fortified grains)
    • Importance of vitamin C for iron absorption
    • Avoiding cow’s milk overconsumption in infants, which can impair iron absorption
    • Adherence to supplements and follow-up appointments
    • Recognizing early signs of anemia recurrence

    Prevention Strategies

    • Promoting exclusive breastfeeding for the first 6 months
    • Timely introduction of iron-rich complementary foods
    • Routine deworming in high-prevalence areas
    • Nutritional support and education in communities
    • Public health screening in schools and health centers

    Why Choose Neftaly?

    • Pediatric-focused, multidisciplinary care teams
    • Evidence-based treatment aligned with WHO and national guidelines
    • Strong focus on nutrition, prevention, and family involvement
    • Accessible services for both urban and rural populations
    • Ongoing education, monitoring, and community outreach

    Helping Children Thrive, One Healthy Cell at a Time

    Anemia in childhood is preventable and treatable. With Neftaly Management of Anemia in Children, we are committed to early intervention, holistic care, and long-term wellness for every child—because every child deserves the chance to grow, learn, and live life to the fullest.

  • Neftaly Management of Diabetes in Primary Care

    Neftaly Management of Diabetes in Primary Care

    Neftaly Management of Diabetes in Primary Care

    Empowering Providers. Supporting Patients. Controlling Diabetes Where It Starts.

    Diabetes is a growing public health challenge affecting millions worldwide. As the frontline of healthcare delivery, primary care settings play a vital role in the early detection, continuous management, and long-term control of diabetes.

    At Neftaly, our Management of Diabetes in Primary Care program equips healthcare professionals with the tools, knowledge, and systems to deliver effective, holistic, and patient-centered diabetes care—right where patients need it most.

    Our Mission

    To improve diabetes outcomes through comprehensive, integrated management strategies within primary care—focusing on prevention, early diagnosis, treatment optimization, and patient empowerment.

    Key Objectives

    • Ensure early detection and accurate diagnosis of Type 1, Type 2, and gestational diabetes
    • Promote individualized, evidence-based treatment and lifestyle support
    • Prevent and manage diabetes-related complications
    • Enhance provider skills and capacity in chronic disease management
    • Strengthen patient education and self-care practices

    Neftaly’s Core Components of Diabetes Management in Primary Care

    1. Early Identification and Screening

    • Routine screening for at-risk populations (obesity, hypertension, family history, etc.)
    • Use of fasting glucose, HbA1c, and oral glucose tolerance tests
    • Opportunistic screening during routine visits or community outreach

    2. Individualized Treatment Plans

    • Lifestyle interventions: diet, physical activity, weight management
    • Pharmacologic therapy initiation and titration (oral agents, insulin, etc.)
    • Culturally tailored care plans that consider socioeconomic and personal factors
    • Management of comorbidities: hypertension, dyslipidemia, cardiovascular risk

    3. Patient Education and Self-Management Support

    • Diabetes self-management education (DSME) for patients and families
    • Training on blood glucose monitoring and insulin use
    • Guidance on nutrition, physical activity, and foot care
    • Addressing psychosocial aspects, including stress, depression, and stigma

    4. Monitoring and Follow-Up

    • Regular HbA1c monitoring (every 3–6 months)
    • Annual screening for retinopathy, nephropathy, and neuropathy
    • Foot examinations and cardiovascular risk assessments
    • Ongoing medication review and adjustment

    5. Provider Training and Capacity Building

    • Clinical training for doctors, nurses, and allied health professionals
    • Standardized treatment protocols and decision-support tools
    • Workshops on communication, motivational interviewing, and care coordination
    • Use of telehealth and digital tools for remote monitoring and follow-up

    6. System Integration and Continuity of Care

    • Strengthen referral pathways to specialists when needed
    • Coordinate care across disciplines (nutrition, pharmacy, mental health)
    • Engage community health workers to support adherence and follow-up
    • Use of electronic health records (EHRs) to track patient progress and outcomes

    Why Neftaly?

    • Evidence-based and WHO-aligned protocols
    • Tailored for resource-limited and high-burden primary care settings
    • Multidisciplinary approach for comprehensive care
    • Culturally responsive and patient-centered philosophy
    • Focus on sustainability through provider education and community engagement

    Better Diabetes Control Starts with Primary Care

    With the right support, primary care providers can be powerful agents in preventing complications, improving quality of life, and reducing the burden of diabetes. Neftaly is here to partner with clinics, healthcare workers, and communities to make that vision a reality.

  • Neftaly Medical Management of Snake Bites

    Neftaly Medical Management of Snake Bites

  • Neftaly Prevention of Hospital Acquired Infections

    Neftaly Prevention of Hospital Acquired Infections

  • Neftaly Role of Nurses in Palliative Care

    Neftaly Role of Nurses in Palliative Care

  • Neftaly Prevention of Teen Pregnancy

    Neftaly Prevention of Teen Pregnancy

  • C

    C